These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22530427)

  • 1. [Resistant bacteria threaten health care. Notification and transmission tracing of resistant intestinal bacteria now introduced].
    Von Rosen IA; Olsson-Liljequist B; Riesenfeld-Orn I; Struwe J; Wisell KT
    Lakartidningen; 2012 Mar 14-20; 109(11):569. PubMed ID: 22530427
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nosocomial infection due to ESBL-producing bacteria].
    Yagi T
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():90-4. PubMed ID: 12717952
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of risk factors for the acquisition of bloodstream infections with extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in the intensive care unit; antibiotic management and clinical outcome.
    Cordery RJ; Roberts CH; Cooper SJ; Bellinghan G; Shetty N
    J Hosp Infect; 2008 Feb; 68(2):108-15. PubMed ID: 18063198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ESBL--increasing resistance problems. Cephalosporins no longer obvious choice in diffuse infections].
    Hallgren H; Gustafsson I; Ripa T
    Lakartidningen; 2007 Dec; 104(51-52):3883-5. PubMed ID: 18232531
    [No Abstract]   [Full Text] [Related]  

  • 5. Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.
    Calfee DP
    J Infus Nurs; 2010; 33(3):150-4. PubMed ID: 20442598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli acquisition in a tertiary care teaching hospital in Thailand.
    Chaiwarith R; Pasogpakdee P; Salee P; Kanjanaratanakorn K; Sirisanthana T; Supparatpinyo K
    J Hosp Infect; 2009 Mar; 71(3):285-6. PubMed ID: 19157645
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical and economic outcomes associated with community-acquired intra-abdominal infections caused by extended spectrum beta-lactamase (ESBL) producing bacteria in China.
    Hu B; Ye H; Xu Y; Ni Y; Hu Y; Yu Y; Huang Z; Ma L
    Curr Med Res Opin; 2010 Jun; 26(6):1443-9. PubMed ID: 20394469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution.
    Fournier S; Lepainteur M; Kassis-Chikhani N; Huang M; Brun-Buisson C; Jarlier V;
    J Travel Med; 2012; 19(5):320-3. PubMed ID: 22943275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
    Akyar I
    Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and characterization of extended spectrum β-lactamases in Klebsiella-Enterobacter-Serratia group bacteria, in Algeria.
    Nedjai S; Barguigua A; Djahmi N; Jamali L; Zerouali K; Dekhil M; Timinouni M
    Med Mal Infect; 2012 Jan; 42(1):20-9. PubMed ID: 22056377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in approach to ESBL Enterobacteriaceae among infection control practitioners: results of an Ontario-wide survey.
    Muller M; McGeer A
    Can Commun Dis Rep; 2002 Aug; 28(15):121-4. PubMed ID: 12168403
    [No Abstract]   [Full Text] [Related]  

  • 12. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J; Pai H; Kim YK; Kim NH; Eun BW; Kang HJ; Park KH; Choi EH; Shin HY; Kim EC; Lee HJ; Ahn HS
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
    Basak S; Mallick SK; Bose S
    J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predominance of CTX-M-15 extended spectrum beta-lactamases in diverse Escherichia coli and Klebsiella pneumoniae from hospital and community patients in Kuwait.
    Ensor VM; Jamal W; Rotimi VO; Evans JT; Hawkey PM
    Int J Antimicrob Agents; 2009 May; 33(5):487-9. PubMed ID: 19097760
    [No Abstract]   [Full Text] [Related]  

  • 15. Extended-spectrum beta-lactamases and clinical outcomes: current data.
    Ramphal R; Ambrose PG
    Clin Infect Dis; 2006 Apr; 42 Suppl 4():S164-72. PubMed ID: 16544267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006)].
    Angel Díaz M; Ramón Hernández J; Martínez-Martínez L; Rodríguez-Baño J; Pascual A;
    Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):503-10. PubMed ID: 19329230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRSA infections decline, but new bacterial strains threaten. You can take action to protect yourself against drug-resistant bacteria.
    Duke Med Health News; 2010 Nov; 16(11):7. PubMed ID: 21186499
    [No Abstract]   [Full Text] [Related]  

  • 18. Bacteriuria by extended-spectrum Beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: isolates in a governmental hospital in South of Tehran, Iran.
    Aminzadeh Z; Sadat Kashi M; Sha'bani M
    Iran J Kidney Dis; 2008 Oct; 2(4):197-200. PubMed ID: 19377237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic impact of extended-spectrum beta-lactamases (ESBL)].
    Cercenado E
    Rev Clin Esp; 2011 Mar; 211(3):139-41. PubMed ID: 21367407
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M; Vera DE; Ramírez-Ronda CH; Saavedra S
    P R Health Sci J; 2004 Sep; 23(3):207-15. PubMed ID: 15631176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.